Drug Shortage Report for VINCRISTINE SULFATE INJECTION
Report ID | 98179 |
Drug Identification Number | 02143305 |
Brand name | VINCRISTINE SULFATE INJECTION |
Common or Proper name | VINCRISTINE INJECTION 1MG/ML |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | VINCRISTINE SULFATE |
Strength(s) | 1MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 5ML |
ATC code | L01CA |
ATC description | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-11-06 |
Estimated end date | 2020-02-29 |
Actual end date | 2020-02-20 |
Shortage status | Resolved |
Updated date | 2020-02-21 |
Company comments | We have 1 and 2ml. available as a substitute for the 5ml. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-11-07 | English | Compare |
v2 | 2019-11-07 | French | Compare |
v3 | 2019-12-19 | English | Compare |
v4 | 2019-12-19 | French | Compare |
v5 | 2020-02-21 | English | Compare |
v6 | 2020-02-21 | French | Compare |
Showing 1 to 6 of 6